Patents by Inventor Lori S. Burton

Lori S. Burton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS COMPRISING AN ANTI-LAG-3 ANTIBODY OR AN ANTI-LAG-3 ANTIBODY AND AN ANTI-PD-1 OR ANTI-PD-L1 ANTIBODY
    Publication number: 20240066123
    Abstract: This provides pharmaceutical compositions that comprise (i) an anti-LAG-3 antibody or antigen binding fragment thereof or (ii) an anti-LAG-3 antibody or antigen binding fragment thereof and an anti-PD-1 antibody, anti-PD-L1 antibody, or antigen binding fragment thereof. Also provided are pharmaceutical compositions that comprise a buffering agent, stabilizing or bulking agent, and a surfactant. The disclosure also provides a vial, syringe, intravenous bag, or kit that comprises the compositions, and methods for using the compositions.
    Type: Application
    Filed: June 16, 2023
    Publication date: February 29, 2024
    Inventors: Lori S. BURTON, William Ying, Nils Lonberg, Sudhir Chakravarthi, Pedro Smith
  • Compositions comprising an anti-LAG-3 antibody or an anti-LAG-3 antibody and an anti-PD-1 or anti-PD-L1 antibody
    Patent number: 11723975
    Abstract: This provides pharmaceutical compositions that comprise (i) an anti-LAG-3 antibody or antigen binding fragment thereof or (ii) an anti-LAG-3 antibody or antigen binding fragment thereof and an anti-PD-1 antibody, anti-PD-L1 antibody, or antigen binding fragment thereof. Also provided are pharmaceutical compositions that comprise a buffering agent, stabilizing or bulking agent, and a surfactant. The disclosure also provides a vial, syringe, intravenous bag, or kit that comprises the compositions, and methods for using the compositions.
    Type: Grant
    Filed: May 30, 2018
    Date of Patent: August 15, 2023
    Assignee: Bristol-Myers Squibb Company
    Inventors: Lori S. Burton, William Ying, Nils Lonberg, Sudhir Chakravarthi, Pedro Smith
  • COMPOSITIONS COMPRISING AN ANTI-LAG-3 ANTIBODY OR AN ANTI-LAG-3 ANTIBODY AND AN ANTI-PD-1 OR ANTI-PD-L1 ANTIBODY
    Publication number: 20210283251
    Abstract: This provides pharmaceutical compositions that comprise (i) an anti-LAG-3 antibody or antigen binding fragment thereof or (ii) an anti-LAG-3 antibody or antigen binding fragment thereof and an anti-PD-1 antibody, anti-PD-L1 antibody, or antigen binding fragment thereof. Also provided are pharmaceutical compositions that comprise a buffering agent, stabilizing or bulking agent, and a surfactant. The disclosure also provides a vial, syringe, intravenous bag, or kit that comprises the compositions, and methods for using the compositions.
    Type: Application
    Filed: May 30, 2018
    Publication date: September 16, 2021
    Applicant: Bristol-Myers Squibb Company
    Inventors: Lori S. BURTON, William YING, Nils LONBERG, Sudhir CHAKRAVARTHI, Pedro SMITH
  • COMPOSITIONS AND METHODS FOR TREATING TAUOPATHIES
    Publication number: 20190135905
    Abstract: Dosage regimens and formulations of anti-human tau antibodies are provided. These formulations and dosage regimens find use in the treatment of tauopathies such as progressive supranuclear palsy and Alzheimer's disease.
    Type: Application
    Filed: June 13, 2018
    Publication date: May 9, 2019
    Applicant: Bristol-Myers Squibb Company
    Inventors: Giridhar S. Tirucherai, Michael Frans Burgess, Masano Tlaneci Huang, Lori S. Burton, Yong Quan
  • Sustained release glp-1 receptor modulators
    Publication number: 20100022457
    Abstract: The present invention provides novel pharmaceutical compositions comprising a human glucagon-like peptide-1 (GLP-1)-receptor modulator as an active ingredient in a sustained release formulation.
    Type: Application
    Filed: November 8, 2006
    Publication date: January 28, 2010
    Inventors: Feng Qian, William R. Ewing, Claudio Mapelli, Douglas James Riexinger, Ving G. Lee, Richard B. Sulsky, Yeheng Zhu, Tasir Shamsul Haque, Rogelio L. Martinez, Vijay Naringrekar, Nina Ni, Lori S. Burton
  • Sustained release GLP-1 receptor modulators
    Patent number: 7534763
    Abstract: The present invention provides novel pharmaceutical compositions comprising a human glucagon-like peptide-1 (GLP-1)-receptor modulator as an active ingredient in a sustained release formulation.
    Type: Grant
    Filed: November 8, 2006
    Date of Patent: May 19, 2009
    Assignee: Bristol-Myers Squibb Company
    Inventors: Feng Qian, William R. Ewing, Claudio Mapelli, Douglas James Riexinger, Ving G. Lee, Richard B. Sulsky, Yeheng Zhu, Tasir Shamsul Haque, Rogelio L. Martinez, Vijay Naringrekar, Nina Ni, Lori S. Burton